Pediapharm Inc. (CVE:PDP – Get Free Report)’s stock price rose 1.7% on Wednesday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares changed hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Performance
The company has a current ratio of 1.12, a quick ratio of 0.71 and a debt-to-equity ratio of 186.87. The firm’s fifty day moving average price is C$0.30 and its two-hundred day moving average price is C$0.30. The stock has a market capitalization of C$66.36 million and a PE ratio of -4.11.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
See Also
- Five stocks we like better than Pediapharm
- How to invest in blue chip stocks
- Comprehensive Analysis of PayPal Stock
- Using the MarketBeat Dividend Tax Calculator
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Investing in Commodities: What Are They? How to Invest in Them
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
